|
Trade Name | MELODY TRANSCATHETER PULMONARY VALVE |
Classification Name | pulmonary valve prosthesis percutaneously delivered |
Generic Name | pulmonary valve prosthesis percutaneously delivered |
Applicant |
Medtronic, Inc |
8200 coral sea street ne mvs83 |
mounds view, MN 55112 |
|
HDE Number | H080002 |
Supplement Number | S007 |
Date Received | 03/01/2012 |
Decision Date | 01/10/2013 |
Product Code | |
Advisory Committee |
Cardiovascular |
Supplement Type | normal 75 day track |
Supplement Reason | change design/components/specifications/material |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval for the glutaraldehyde stock solution that is obtained from dow chemical for the fixative, storage, and sterilization solutions to be changed from a 25%stock solution to a 50% stock solution and is indicated for the following uses: for the contegra pulmonary valved conduit: correction or reconstruction of the right ventricular outflow tract (rvot) in patients aged less than 18 years with any of the following congenital heart malformations:1) pulmonary stenosis2)tetralogy of fallot" truncus arteriosus3) transposition with ventricular septal defect (vsd)" pulmonary atresia. In addition, the conduit is indicated for the replacement of previously implanted, but dysfunctional, pulmonary homografts or valved conduits. For the melody transcatheter pulmonary valve:as an adjunct to surgery in the management of pediatric and adult patients with the following clinical conditions: " -existence of a full (circumferential) rvot conduit that was equal to or greater than 16 mm in diameter when originally implanted and "dysfunctional right ventricular outflow tract (ryot) conduits with a clinicalindication for intervention, and either:a) regurgitation: ! moderate regurgitation, orb) stenosis: mean rvot gradient>: 35 mmhg. |